Linked from

The 16 pages that link to Raynaud syndrome, each with the reason it gives.

• VasoconstrictionBroader topic: Exaggerated digital-vessel constriction causes its characteristic color and sensation changes.

• Beta blockerRelated: Beta blockers can aggravate peripheral vasoconstriction in some people.

• Calcium channel blockerRelated: Vasodilation from dihydropyridines can reduce attacks.

• FrostbiteRelated: Its episodic reduction of extremity blood flow can increase vulnerability to cold injury.

• AmlodipineRelated: Amlodipine is sometimes used off-label to reduce attacks through peripheral vasodilation.

• CyanosisRelated: Reduced local blood flow can cause episodic peripheral cyanosis.

• SildenafilRelated: Sildenafil has been studied and used off label to improve blood flow in severe cases.

• Systemic sclerosisRelated: This frequent early manifestation reflects the small-vessel dysfunction that also contributes to tissue injury.

• ErythromelalgiaCompared with: Raynaud attacks are typically triggered by cold and involve vasoconstriction, unlike the heat-triggered redness of erythromelalgia.

• NifedipineRelated: Nifedipine’s vasodilating effect is used to reduce attacks in some patients.

• DiltiazemRelated: Diltiazem is sometimes used off-label to reduce vasospastic attacks.

• PapaverineRelated: Its vasodilating action relates to treatment approaches for digital vasospasm.

• ChilblainsCompared with: Both conditions involve cold-sensitive circulation, but Raynaud phenomenon causes color changes rather than persistent lesions.

• ErgotamineRelated: Ergotamine's vasoconstriction can worsen peripheral circulation and is unsafe in this condition.

• SclerodactylyRelated: It commonly precedes sclerodactyly in systemic sclerosis and reflects related vascular disease.

• Thromboangiitis obliteransRelated: It can accompany the disease and precede more persistent ischemia.